Navigating rare disease medications: A pharmacist’s primer-Reference-Cited by-同舟云学术

Navigating rare disease medications: A pharmacist’s primer

Published:2024-01-30 Issue:2 Volume:157 Page:50-52
ISSN:1715-1635
Container-title:Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
language:en
Short-container-title:Can Pharm J

Author:

Shakeri Ahmad¹²,Abdul Aziz Yasmin¹,Tadrous Mina¹²^ORCID

Affiliation:

1. Leslie Dan Faculty of Pharmacy, University of Toronto

2. Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/17151635241228274

Reference10 articles.

1. Ward L, Chambers A, Mechichi E, Wong-Rieger D, Campbell C. An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries. Orphanet J Rare Dis. 2022;17:113. Available: https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02260-6#citeas (accessed Oct. 15, 2023).

2. Health Canada. Government of Canada improves access to affordable and effective drugs for rare diseases. March 22, 2023. Available: https://www.canada.ca/en/health-canada/news/2023/03/government-of-canada-improves-access-to-affordable-and-effective-drugs-for-rare-diseases.html (accessed Oct. 15, 2023).

3. House of Commons Standing Committee on Health. Canadians affected by rare diseases and disorders: improving access to treatment. Ottawa (ON): House of Commons Standing Committee on Health; 2019. Available: https://www.ourcommons.ca/Content/Committee/421/HESA/Reports/RP10349306/hesarp22/hesarp22-e.pdf (accessed Jan. 4, 2023).

4. Canadian Organization for Rare Disorders. About CORD. 2023. Available: https://www.raredisorders.ca/about-cord/#:~:text=Ararediseaseisa,affectedbyararedisease (accessed Oct. 15, 2023)